Used in research and diagnostic applications targeting insulin-like growth factor 2 (IGF2) pathways. It serves as a reference antibody in immunoassays to detect, quantify, and neutralize IGF2, a protein involved in cell growth and development. Commonly applied in studies related to cancer, particularly tumors where IGF2 signaling is dysregulated, such as hepatocellular carcinoma and Wilms' tumor. Also utilized in pharmacokinetic and pharmacodynamic studies during the development of IGF2-targeting therapeutics to assess target engagement and biological activity. Suitable for techniques including ELISA, Western blotting, and immunohistochemistry.